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Aortic dissection (AD) is a devastating, heterogeneous condition of aorta. The homeostasis between collagens and matrix
metalloproteases (MMPs)/tissue inhibitors of MMPs (TIMPs) system in the extracellular matrix plays an important role
for structure and functions of aorta. However, our knowledge on association between variants of genes in this system and
pathogenesis of AD is very limited. We analyzed all yet known coding human genes of collagens (45 genes), MMPs/TIMPs (27
genes) in 702 sporadic AD patients and in 163 matched healthy controls, by using massively targeted next-generation and Sanger
sequencing. To define the pathogenesis of potential disease-causing candidate genes, we performed transcriptome sequencing
and pedigree co-segregation analysis in some genes and generated Col5a2 knockout rats. We identified 257 pathogenic or
likely pathogenic variants which involved 88.89% (64/72) genes in collagens-MMPs/TIMPs system and accounted for 31.05%
(218/702) sporadic AD patients. In them, 84.86% patients (185/218) carried one variant, 12.84% two variants and 2.30% more
than two variants. Importantly, we identified 52 novel probably pathogenic loss-of-function (LOF) variants (20 nonsense, 16
frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163
controls (P=2.5×10−5). Transcriptome sequencing revealed that identified variants induced dyshomeostasis in expression of
collagens-TIMPs/MMPs systems. The Col5a2−/− rats manifested growth retardation and aortic dysplasia. Our study provides
a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests that
variants of these genes contribute largely to AD pathogenesis.
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INTRODUCTION
Aortic dissection (AD) is a disease of life-threatening emer-
gency associated with high mortality and is difficult to be pre-
dicted (Gao et al., 2016; Nienaber and Eagle, 2003; Suzuki et
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al., 2009). AD usually occurs in non-syndromic and sporadic
form (~80%) or in association with hereditary genetic dis-
orders, such as familial thoracic aortic dissection (fTAAD),
Marfan syndrome (MFS), the vascular type of Ehlers-Danlos
syndrome (EDS), Loeys-Dietz syndrome (LDS), and arterial
tortuosity syndrome (ATS) (Goldfinger et al., 2014; Guo et
al., 2011; Hoffjan, 2012; Khau Van Kien et al., 2004; Ritelli
et al., 2009). Although previous genetic studies in familial
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AD cases have identified several genes (Table S1 in Support-
ing Information) responsible for this disease, large fraction
of clinical cases, especially sporadic cases, still lack genetic
targets (Campens et al., 2015; Guo et al., 2011).
Except for a genome-wide association study (GWAS),
no previous studies have systematically investigated the
genetic basis of sporadic spontaneous AD or the relationship
between genotype and phenotype heterogeneity, especially
for collagens and matrix metalloproteases (MMPs)/tissue
inhibitors of MMPs (TIMPs) (LeMaire et al., 2011). How-
ever, GWASs were performed using only known genetic
markers involved in both cases and healthy controls, the
ability to identify novel pathogenesis is limited compared
with direct sequencing (Marian and Belmont, 2011; Salomon
et al., 2016). It is clear that the imbalance of the homeostasis
between collagens and MMPs/TIMPs system is a key re-
sponsible for extracellular matrix (ECM) degeneration and
structure and functions of aorta, and therefore may contribute
to the pathogenesis of AD (Barbour et al., 2007; Theruvath
et al., 2012; Tsamis et al., 2013). However, to date, except
for gene COL3A1, no pathogenic genes in collagens and
MMP/TIMPs system have been demonstrated in AD patients
(Sakai et al., 2012; Smith et al., 2011).
To systematically study the pathogenic basis of genes in
collagens and MMP/TIMPs system in sporadic AD, we se-
quenced all 72 related genes in the system in 702 patients
with sporadic AD and in 163 matched healthy controls. Ac-
cording to the guideline (Richards et al., 2015), we identi-
fied 257 pathogenic or likely pathogenic variants in 31.05%
(218/702) patients, including 52 novel probably pathogenic
loss-of-function (LOF) variants.
RESULTS
Targeted resequencing output and quality
We obtained sequence data for 2,496 amplicons of 2,279 ex-
ons from 72 targeted genes for 702 sporadic AD patients and
165 controls. On average, we gained 4,756,177mapped reads
per sample with a mean base coverage depth of 716-fold.
In summary, 99.70% of the target amplicons were covered
at least once, 98.62% were covered at least 20 times, and
96.06% were covered at least 100 times in coding regions.
Identification of pathogenic or likely pathogenic variants
Using stringent criteria (Richards et al., 2015), in all we iden-
tified two pathogenic and 255 likely pathogenic variants in the
72 genes in 31.05% (218/702) of the AD patients, and most
of these genes harbored more than one likely pathogenic mu-
tation (Figure 1 and Table S2 in Supporting Information).
Importantly, we identified 52 probably pathogenic LOF
variants in collagens or MMPs/TIMPs genes in the 702 AD
cases. We did not observe any pathogenic or probably path-
Figure 1   The LOF and likely pathogenic variants identified in 702 AD
cases. This panel shows the 54 novel identified LOF and likely pathogenic
variants identified in 702 AD patients of collagens and MMPs/TIMPs genes.
The LOF variants are shown in black and likely pathogenic variants are
shown in red.
ogenic LOF variants in these genes in the 165 controls
(P=2.5×10−5). These LOF variants include 20 nonsense,
16 frameshift, 14 splice-sites, one stop-loss, and one ini-
tiation-codon-break (Table 1). In addition, none of these
LOF variants carriers had potential pathogenic variants in
the 12 known AD pathogenic genes (Table S1 in Supporting
Information).
Copy number variation (CNV) analysis
To evaluate the copy number across the targeted genes and
to identify potential large heterozygous or homozygous dele-
tion, the copy number of all sequenced regions of the 702
cases and 163 controls using Ion reporter 5.0. CNVs were
analyzed and then further validated by real-time PCR. How-
ever, we did not find any large deletion in all participants.
Correlations between phenotype and genotype
It is clear that sporadic AD presents high genetic hetero-
geneity, as at least 64 genes are implied to responsible for
its pathogenesis in our study. The genotype-phenotype
relationship is complex in this disease. We firstly found
genes that were previously thought to be associated with
specific syndromes (COL4A3, COL4A4, COL4A5: Al-
port syndrome, COL6A3, COL6A6, COL6A5: Bethlem
myopathy, COL18A1: Knobloch syndrome, COL14A1:
punctate palmoplantar keratoderma, MMP19: Cavitary
optic disc anomalies, and COL7A1: Epidermolysis bullosa
dystrophica) (Theocharis et al., 2016) also contribute to
non-syndromic sporadic AD pathogenesis. We did not
identify related symptoms in our AD patients after carefully
examination. Furthermore, the same pathogenic or likely
pathogenic variants were never shared by more than four
patients  in  our  study,  and most of the variants were unique
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Table 1    LOF and pathogenic variants in collagens and MMPs/TIMPs coding genes for 702 AD patientsa)
Count* Gene name Variant function Protein change Coding change Novelty
1 COL10A1 Initiation codon p.Met1Thr c.2T>C Novel
1 COL12A1 Nonsense p.Arg3035Ter c.9103C>T Novel
1 COL14A1 Nonsense p.Arg1473Ter c.4417C>T Novel
1 COL16A1 Frameshift deletion p.Gln992fs c.2974_2974delC Novel
1 COL16A1 Splicesite_5 − chr1:32155995_32155996delCT Novel
1 COL18A1 Frameshift insertion p.Pro1286fs c.3852_3853insCA Novel
1 COL18A1 Frameshift insertion p.Asp1296fs c.3885_3886insC Novel
1 COL18A1 Nonsense p.Glu378Ter c.1132G>T Novel
1 COL18A1 Splicesite_5 − chr21:46912599A>G Novel
2 COL20A1 Frameshift insertion p.Leu613fs c.1835_1836insCGG Novel
1 COL21A1 Frameshift insertion p.Tyr392fs c.1173_1174insA Novel
1 COL21A1 Splicesite_3 − chr6:55929375C>T Novel
1 COL24A1 Frameshift deletion p.Glu450fs c.1347_1347delA Novel
1 COL24A1 Nonsense p.Arg1206Ter c.3616C>T rs187705574
1 COL28A1 Frameshift deletion p.Ser1020fs c.3059_3059delC Novel
1 COL2A1 Splicesite_5 − chr12:48373349_48373350delTG Novel
2 COL3A1 Missense p.Ala1259Val c.3776C>T CM122891**
1 COL3A1 Splicesite_3 − chr2:189868871T>A Novel
1 COL4A3 Frameshift Block substitution p.Pro553fs c.1657_1664delCCAGGTGAinsT Novel
1 COL4A4 Stoploss p.Ter1691Tyr c.5073G>C Novel
1 COL5A2 Splicesite_3 − chr2:189922044A>T Novel
1 COL5A3 Splicesite_5 − chr19:10099854C>G Novel
1 COL6A3 Nonsense p.Gln1760Ter c.5278C>T Novel
1 COL6A5 Frameshift deletion p.Arg1384fs c.4146_4147delAG Novel
1 COL6A5 Frameshift insertion p.Ala568fs c.1699_1700insG Novel
1 COL6A5 Splicesite_3 − chr3:130188326G>T Novel
1 COL6A5 Splicesite_5 − chr3:130098259A>G Novel
4 COL6A6 Nonsense p.Arg1480Ter c.4438A>T rs140413590




1 COL7A1 Frameshift insertion p.Gly2233fs c.6696_6697insC Novel
1 COL7A1 Nonsense p.Arg1343Ter c.4027C>T Novel
1 COL8A1 Nonsense |p.Arg225Ter c.673C>T Novel
1 MMP1 Frameshift deletion p.Asp408fs c.1222_1222delG Novel
1 MMP1 Splicesite_3 − chr11:102663334A>T Novel
1 MMP1 Splicesite_5 − chr11:102661539T>C Novel
1 MMP10 Frameshift deletion p.Asp193fs c.576_580delAGATA Novel
1 MMP17 Frameshift deletion p.Tyr512fs c.1534_1534delT Novel
2 MMP19 Nonsense p.Arg408Ter c.1222C>T Novel
4 MMP19 Nonsense p.Gln5Ter c.13C>T rs17844787
1 MMP27 Nonsense p.Gln330Ter c.988C>T Novel
1 MMP28 Nonsense p.Arg391Ter c.1173C>T Novel
1 MMP28 Nonsense p.Gln49Ter c.145C>T Novel
1 MMP8 Frameshift deletion p.Lys39fs c.117_117delG Novel
1 MMP8 Splicesite_5 − chr11:102584189C>T Novel
a) *, indicates count of the variants in AD patients; **, CM122891 is the pathogenic number in HGMD database.
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to single patient. These results indicate that there is no
“hotspot” in this disease.
In all explained cases, 12.84% (28/218) harbored two vari-
ants, 1.83% (4/218) harbored three variants and one harbored
four variants. We investigated the patients who had multiple
variants and found that they suffered fromAD in earlier onset
age (Figure 2A), and lower percentage of DeBaKey Type 3
AD (mild type of AD) (Figure 2B).
To evaluate the effect of these AD-associated genes in
different systems, we compared the average AD onset age
between collagens and MMPs/TIMPs genes (Figure 2C),
as well as percentage of DeBaKey Type 3 AD (Figure 2D).
Results showed that there is no significant difference of AD
onset age or severity between collagens and MMPs/TIMPs
genes. However, if patients carried them in both systems,
they were observed to suffer from worse prognosis (Figure
2C and D).
Pedigree co-segregation analysis
We performed pedigree co-segregation analysis of a 45-yeay-
old-onset AD patient (AD337, II-1), who carried only a non-
sense variant of COL14A1 (Figure 3A). The father (I-1) died
Figure 2   Correlations between phenotype and genotype. A, Average onsetage of AD patients carried different number of pathogenic or likely pathogenic
variants. The error bars indicate standard error (SE). *, P<0.05. B, Percentage of DeBaKey type 3 AD cases in different number of pathogenic or likely
pathogenic variants. C, Average onsetage of AD patients carried pathogenic or likely pathogenic variants in different genes. The error bars indicate standard
error (SE). D, Percentage of DeBaKey type 3 AD cases in different genes.
Figure 3   Pedigree co-segregation analysis. A, The pedigree co-segregation analysis of a COL14A1 nonsense variant carried AD patient (AD337). B, The
pedigree co-segregation analysis of a COL6A5 frameshift deletion variant carried AD patient (AD606).
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because of AD at the same age of the proband. The proband
and his son (III-1), 20-year-old, carried the same variant in
COL14A1 (p.Arg1473Ter). All other their relatives are of
wild type. Maybe his son is too young to develop AD. All
pathogenic and likely pathogenic variants we identified in
sporadic AD cases are heterozygous, implying that there
might be de novo variants. In order to validate this assump-
tion, we sequenced all healthy relatives of AD patient AD606
with a COL6A5 frameshift variant, and the results supported
our hypothesis (Figure 3B).
Col5a2 knockout rats display thoracic aortic dysplasia
To evaluate the pathogenesis of COL5A2 gene defect in AD,
we generated four Col5a2 knockout rats (Col5a2−/−) by in-
ducing a large deletion containing the exon 1 of Col5a2. The
four Col5a2−/− rats showed growth retardation. Histological
analysis revealed thoracic aortic dysplasia at nine weeks. In
the lesion region, the media was demonstrated loss of smooth
muscle cells. The elastin fibers were loss, disarray and frag-
mentation in the same region. In the rest part of the loose
hyperplasia media there was increased collagen deposition
versus control. The adventitia is loose from the media and
showed hyperplasia (Figure 4). These changes are similar to
pathology of human aorta dissection.
The mRNA-expression analysis
Firstly, we detected all selected genes except for MMP7 by
transcriptome sequencing in healthy control aortas. Anal-
ysis of mRNA-expression revealed that TIMP1, COL6A2,
COL1A1, COL1A2, TIMP3, COL3A1, COL4A2 andCOL4A1
were most aorta-enriched in healthy control aortas (Figure S1
in Supporting Information).
BymRNA-expression analysis, we found that seven of nine
variants (one LOF variant and eight missense variants) result
in significant downregulation of their corresponding mRNA
in aorta wall of AD patients while one splice variant and
other two missense variants result in significant upregulation
of their mRNAs (Figure S2A and B in Supporting Informa-
tion). Interestingly, these three upregulated genes are all most
enriched genes in normal aorta, which indicate that the upreg-
ulation of these genes may largely affect the ECM structure
of aorta wall.
We investigated the expressed mRNA profiles of one pa-
tient who carried FBN1 frameshift pathogenic variant and
six patients who carried collagens or MMPs/TIMPs likely
pathogenic variants compared with healthy controls. Impor-
tantly, we found that TIMP3 and TIMP1 were downregulated
in FBN1-affected AD profile, but TIMP1 was significantly
unregulated in collagen-related AD profiles. This indicates
that the pathogenic mechanism of collagen-related AD is dif-
ferent from classic FBN1-affected AD.
Relationship between common SNP and collagen or
MMPs/TIMPs related AD pathogenesis
To investigate the common SNPs’ contribution of collagen
and MMPs/TIMPs  related  AD  pathogenesis, we compared
Figure 4   The histological staining of a thoracic aortic lesion region of Col5a2−/− rat and control at nine weeks. A, Sirius red staining of the thoracic aortic
lesion region of Col5a2−/− rat. Bar=200µm. B, Sirius red staining of the thoracic aortic of a wild type rat. Bar=200µm. C, Higher magnification of the lesion
region of the arterial wall of a Col5a2−/− rat showing less elastin fibers in the loose hyperplasia media. Bar=50µm. D, Higher magnification of the control
artery. Bar=50µm. E, The thoracic aortic lesion region of a Col5a2−/− rat was stained with mouse anti-α-smooth muscle actin. Arrow indicates loss of smooth
muscle cells in the lesion region of the media. Bar=50µm. F, Van Gieson staining of the thoracic aortic lesion region of a Col5a2−/− rat. Arrow indicates loss,
disarray and fragmentation of the elastin fibers in the lesion region of the media. Bar=50µm.
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the minor allele frequency of all SNPs located in exons in the
72 genes between AD cases and controls. However, there is
no significantly statistical difference, which implies that rare
variants might be the key points of AD pathogenesis.
DISCUSSION
To our knowledge, this is a first comprehensive targeted rese-
quencing study specifically for genetic alterations in genes of
collagens and MMPs/TIMPs system in sporadic AD patients
to date. We identified a series of LOF and likely pathogenic
variants in selected new genes in 702 AD patients, indicat-
ing important new causes of the pathogenesis of this disease
(Figure 1 and Tables 1 and S3 in Supporting Information).
Besides, pedigrees co-segregation analysis and mRNA-ex-
pression analysis further support these genes are responsible
for AD pathogenesis. Finally, we demonstrate that COL5A2
is a novel disease causing gene of sporadic AD by Col5a2−/−
knock-out rat models.
The COL5A1, COL5A2 and COL5A3 genes encode type V
fibrillar collagen (Connizzo et al., 2015). Pathogenic variants
in these genes were previously deemed to cause EDS classic
type (Connizzo et al., 2015; Ritelli et al., 2013). Classic type
EDS are rare autosomal dominant connective tissue disorders
that are characterized by skin hyperextensibility, abnormal
wound healing/atrophic scars, joint hypermobility and should
exclude aortic defects (Ritelli et al., 2013). However, our
study provided evidences that these genes also take part in AD
pathogenesis. Similarly, COL3A1, COL24A1 and COL2A1
are also fibrillar-coding collagens, and are widely and abun-
dantly expressed in aorta walls (Theocharis et al., 2016). Mu-
tations of these genes and consequential structure of abnormal
collagens will directly reduce the fastness of aorta.
Collagen type VI (COL6A6,COL6A5,COL6A3) are identi-
fied most LOF variants in our study, and the relationship with
AD pathogenesis was supported by mRNA-analysis as well
as pedigree co-segregation analysis. Previous study associ-
ated collagen type VI with Bethlem myopathy (Fitzgerald et
al., 2013). However, our LOF variants affected AD patients
did not have related symptoms or family history after care-
fully physical examination and inquiry. Collagen type VI and
type XXVIII (COL28A1) belongs to Beaded-filament-form-
ing collagens, which interact with various ECM proteins, and
they are thus important in ECM protein binding and co-local-
ization (Theocharis et al., 2016).
Collagen type XVIII (COL18A1) is a multiplexin, involv-
ing in production of endostatin which potently inhibits en-
dothelial cell proliferation (Theocharis et al., 2016). mRNA-
analysis found that COL18A1was enriched in healthy human
aorta, and a splice variant in our AD patient resulted in nine
times elevation in COL18A1 mRNA in aorta compared with
the controls (Figure 5A and C).
In addition, Collagen type VII (COL7A1) is an anchor-
ing fibril; type X (COL10A1), VIII (COL8A1) and IV
(COL4A3, COL4A4) are networking-forming collagens; type
XII (COL12A1), XIV (COL14A1), XVI (COL16A1), XX
(COL20A1), XXI (COL21A1) are FACITs (fibril-associated
collagens with interrupted triple helices) (Theocharis et al.,
2016). They anchor or connect with various ECM elements,
and provide aorta capable and flexible. The LOF variants
in these genes may break the inner connection of ECM,
thereupon interrupt the homeostasis of ECM.
The MMPs/TIMPs have robust associations with AD in
association studies (Song et al., 2013; Wang et al., 2014;
Zhang et al., 2009), indicating that functional variants within
MMPs/TIMPs genes may lead to degrading of various com-
ponents of the aortic ECM or result in aorta inflammation,
therefore, playing an important role in AD pathogenesis
(Theruvath et al., 2012). However, none of the MMPs
coding genes have been regarded as AD-causing gene in the
past. Our data identified LOF (four frameshift deletion; five
nonsense; three splice site) and likely pathogenic variants in
MMPs in AD patients for the first time.
Although our study identify a series of LOF and like patho-
genic variants in sporadic AD patients, missing heritability
still remains, which indicates that targeted sequencing is not
enough to find full spectrum of sporadic AD. More compre-
hensive strategies such as whole exome sequencing or whole
genome sequencing should be considered in future studies.
In conclusion, this is a first study on targeted resequenc-
ing of the genes in all collagens and MMPs/TIMPs system
in large scale AD patients to date, and provide a comprehen-
sive map of genetic alternations in this system. We identified
COL5A2 as novel sporadic AD pathogenic genes. We also
highlight collagen type VI (COL6A6, COL6A5, COL6A3),
COL18A1, andMMP19 genes in AD pathogenesis. Our data
also indicate that next-generation targeted resequencing may
be a powerful and effective method for the genetic diagnosis
of AD, which can be used for risk stratification among pa-
tients’ first-degree relatives.
MATERIALS AND METHODS
Study design and eligibility
In this study, we recruited two cohorts of Han Chinese
descent, including 702 sporadic AD patients (cases) and
163 matched unrelated healthy volunteers (controls). Re-
cruitment of the participants was conducted at the Tongji
Hospital. The cases were selected from patients with AD as
defined by computed tomography (CT) or magnetic reso-
nance imaging. The controls were randomly recruited from
healthy individuals undergoing routine health examinations.
All controls were determined to be free of AD bymedical his-
tory inquiry and definitive imaging examinations including
ultrasonography and CT. All enrolled participants underwent
a review of medical history, physical examinations, several
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laboratory assessments of AD risk factors and a consultation
to determine their ethnic origin.
This study was approved by the Institutional Review Board
of Tongji Hospital. Written informed consent was obtained
from all participants. All the experiments were conducted
according to the principles expressed in the Declaration of
Helsinki.
Gene selection
To systemically study genetic defects of genes in collagens
and MMPs/TIMPs system in pathogenic process in AD, we
collected all thus far known human genes coding collagens
and MMPs/TIMPs for resequencing, including 45 collagen
coding genes, 23MMPs coding genes and four TIMPs coding
genes (Table S3 in Supporting Information).
Targeted semiconductor sequencing
Genomic DNA was extracted from blood samples of all par-
ticipants and was diluted to 5 ng μL−1. We performed next-
generation semiconductor sequencing using the Ion torrent
platform. Briefly, adapter-ligated libraries were constructed
using the Ion AmpliSeqTM Library Kit 2.0 and custom-or-
dered multiplex PCR primer pools (Life Technologies, USA)
following the manufacturer’s protocol. After purification, li-
braries were quantitated using a Qubit 2.0 fluorometer (In-
vitrogen, USA) and were combined at equal molar ratios for
sequencing as previously described (Li et al., 2014).
Bioinformatic analysis
The next-generation sequencing data were initially processed
using the Ion Torrent platform-specific software Torrent Suite
v5.0. The sequences were aligned to the hg19/GRCh37 hu-
man reference genome to analyze the coverage and call vari-
ants. Then, all variants were annotated using Ion reporter 5.0.
We removed common variants in the 1000-Genomes-Project
database, the UCSC common SNP database, the Exome Ag-
gregation Consortium (ExAC) database, and the Exome Se-
quencing Project (ESP). To predict the possible impact of de-
tected non-synonymous variants in the exons on the encoded
proteins, all the missense substitutions were scored and pre-
dicted using SIFT and PolyPhen-2. The degrees of conserva-
tion across multiple species of the non-synonymous variants
were estimated by the Grantham and phyloP scores.
Criteria for pathogenic and likely pathogenic variants
We divided the AD-associated variants into “pathogenic” and
“likely pathogenic” according to the guideline (Richards et
al., 2015). The following criteria were used to determine that
a variant was pathogenic: it should be validated by Sanger
sequencing; and it should have been reported as causal vari-
ants in the NCBI ClinVar database or HGMD database.
The following criteria were used to determine that a vari-
ant was likely pathogenic: it should be found in one or more
cases and be absent in all healthy controls; it should be vali-
dated by Sanger sequencing; it should not be found as com-
mon SNP in the 1000-Genomes-Project database, the UCSC
common SNP database, the ExAC database, and the ESP; it
should be an exonic non-synonymous variant or canonical±2
splice sites; if it is a missense substitution, it should be pre-
dicted conservative by Grantham or phyloP score; and both
of the SIFT and Polyphen-2 bioinformatic predictions should
be damaging.
Sanger sequencing validation
PCR amplification was optimized in accordance with the
manual for Taq™ Hot Start version (TaKaRa, Japan). To
exclude any possible false-positive errors, Sanger sequenc-
ing was performed for all pathogenic or likely pathogenic
variants using the Big Dye v.1.1 terminator cycle sequencing
kit and an Applied Biosystems 3500xl capillary sequencer
(Applied Biosystems, CA). The technically uncovered 3,972
bp regions of the 72 selected genes were sequenced directly
by Sanger sequencing.
Statistical analysis
Fisher exact test was used to assess the difference in variant
frequencies between cases and controls. The statistical anal-
ysis was performed with the use of SPSS software, version
20.0 (SPSS). A two-sided P value of less than 0.05 was con-
sidered to indicate statistical significance.
Gene expression analysis
We performed transcriptome sequencing and real-time PCR
to evaluate the tissue expression of some identified novel
genes that may be responsible for AD pathogenesis in aorta
tissue from seven AD patients who underwent aortic surgery.
Total RNA was extracted from frozen human aorta tissue us-
ing a TRIzol Reagent (Invitrogen). For real-time PCR, total
RNA was reverse-transcribed to cDNA using M-MLV First
Strand Kit (Invitrogen), and amplified using Power SYBR
Green PCR Master Mix (Invitrogen) on Step One Plus real
time PCR system (Applied Biosystems). We performed com-
prehensive RNA sequencing of aorta samples of AD patients,
as well as healthy controls using Ion AmpliSeq™ Transcrip-
tome Human Gene Expression Research Panel (Life Tech-
nologies) following the manufacturer’s protocol (https://ion-
community.thermofisher.com/docs/DOC-8980), and analysis
the data by using Ion reporter 5.0.
Preparation of Col5a2 knockout rats
SD rats were bred in standard cages in an Assessment and
Accreditation of Laboratory Animal Care-accredited SPF an-
imal facility. All animal protocols were approved by the An-
imal Care and Use Committees of the Institute of Laboratory
Animal Science of Chinese Academy of Medical Sciences
(ILAS-GC-2015-002).
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The paired synthesized oligonucleotides for sgRNAs were
annealed and cloned into the pUSD-sgRNA expression vec-
tor (#51132, Addgene, USA) before in vitro transcription and
microinjection. The Cas9 expression plasmid (#44758, Ad-
dgene) was linearized with Age I and used as the template
for in vitro transcription using the T7 Ultra Kit (AM1345,
Ambion, USA). sgRNA expression plasmids were linearized
with Dra I and used as templates for in vitro transcription
using the MEGAshortscript Kit (AM1354, Ambion). Tran-
scribed Cas9 mRNA and sgRNA were both purified by us-
ing the MEGAclear Kit (AM1908, Ambion). SD rats were
purchased from Beijing Vital River Laboratories animal cen-
ter are housed in standard cages and maintained on a 12-h
light/dark cycle with food and water. The microinjection of
fertilized rat eggs was performed in Zhang’s lab, Institute of
Laboratory Animal Science, Chinese Academy of Medical
Sciences. New pups genomic DNA was extracted from the
tails of 7-day-old rats for sequencing. Rats with wanted mu-
tations were prepared for consequence experiment.
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